Passage BIO, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
ONE COMMERCE SQUARE, PHILADELPHIA, PA, 19103
Mailing Address
ONE COMMERCE SQUARE, PHILADELPHIA, PA, 19103
Phone
2678660312
Fiscal Year End
1231
EIN
822729751
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 8-K Current report of material events | March 10, 2026 | View on SEC |
| 10-K Annual financial report | March 3, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | January 12, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 4 Insider stock transaction report | January 12, 2026 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
Annual Reports
10-K
March 3, 2026
- Passage BIO is a genetic medicines company focused on developing gene therapies for rare genetic brain and spinal cord disorders.
- The company leverages scientific expertise and proprietary technologies to address unmet medical needs.
Material Events
8-K
Strategy Change
March 10, 2026
High Impact
- Streamlines operations and strengthens financial position through proactive management.
- Sharpens focus on core mission: advancing promising drug candidates for neurological diseases.
Insider Trading
SELL
2 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.